Scholarlink

Objective <p>To observe the clinical efficacy of gentle moxibustion at different temperatures in treating people with diarrhea-predominant bowel syndrome (IBS-D) due to spleen deficiency.</p> Methods <p>A total of 108 IBS-D patients were divided into two groups using the random number table method, with 54 participants in each group. Moxibustion group 1 received gentle moxibustion at (43±1) °C at bilateral Tianshu (ST25) and Zusanli (ST36), lasting 30 min each session; moxibustion group 2 received gentle moxibustion at (37±1) °C at the same points. Both groups received the intervention 3 times weekly for a total of 18 sessions. Abdominal pain intensity, stool form, pattern-based efficacy, quality of life, and mental health assessments were performed at weeks 0, 3, 6, and 8.</p> Results <p>The total effective rate for abdominal pain intensity was 87.8% in moxibustion group 1 versus 51.1% in moxibustion group 2, and the difference was statistically significant (<i>P</i>&lt;0.05). When the treatment finished, abdominal pain intensity, the Bristol score, IBS-symptom severity scale (IBS-SSS) score, self-rating anxiety scale (SAS) score, and self-rating depression scale (SDS) score dropped significantly in both groups (<i>P</i>&lt;0.05), and the IBS-quality of life (IBS-QOL) score increased markedly (<i>P</i>&lt;0.05). Between-group comparisons demonstrated that abdominal pain intensity, the Bristol general score, IBS-SSS score, traditional Chinese medicine (TCM) pattern score, and SDS score were significantly lower in moxibustion group 1 than in moxibustion group 2 at treatment week 6 (<i>P</i>&lt;0.05), and the IBS-QOL score was notably higher in moxibustion group 1 (<i>P</i>&lt;0.05).</p> Conclusion <p>Whether at 43 °C or 37 °C, gentle moxibustion at Tianshu (ST25) and Zusanli (ST36) can improve abdominal pain, stool form, and quality of life, reduce disease severity, and mitigate TCM pattern in IBS-D patients; 43 °C gentle moxibustion performs better than 37 °C gentle moxibustion in improving abdominal pain, stool form, disease severity, TCM pattern, quality of life, anxiety, and depression in IBS-D.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Observation of the clinical efficacy of moxa-stick moxibustion in treating diarrhea-predominant irritable bowel syndrome

  • 期刊论文

  • 发表日期：

    2025年2月22日

查看全文
  • Jindan Ma,
  • Guona Li,
  • Fangyuan Sun,
  • Qin Qi,
  • Luyi Wu,
  • Chen Zhao,
  • Huirong Liu,
  • Yuan Lu,
  • Xiaopeng Ma,
  • Liming Chen,
  • Zhaoqin Wang,
  • Cili Zhou,
  • Huangan Wu

摘要

Objective

To observe the clinical efficacy of gentle moxibustion at different temperatures in treating people with diarrhea-predominant bowel syndrome (IBS-D) due to spleen deficiency.

Methods

A total of 108 IBS-D patients were divided into two groups using the random number table method, with 54 participants in each group. Moxibustion group 1 received gentle moxibustion at (43±1) °C at bilateral Tianshu (ST25) and Zusanli (ST36), lasting 30 min each session; moxibustion group 2 received gentle moxibustion at (37±1) °C at the same points. Both groups received the intervention 3 times weekly for a total of 18 sessions. Abdominal pain intensity, stool form, pattern-based efficacy, quality of life, and mental health assessments were performed at weeks 0, 3, 6, and 8.

Results

The total effective rate for abdominal pain intensity was 87.8% in moxibustion group 1 versus 51.1% in moxibustion group 2, and the difference was statistically significant (P<0.05). When the treatment finished, abdominal pain intensity, the Bristol score, IBS-symptom severity scale (IBS-SSS) score, self-rating anxiety scale (SAS) score, and self-rating depression scale (SDS) score dropped significantly in both groups (P<0.05), and the IBS-quality of life (IBS-QOL) score increased markedly (P<0.05). Between-group comparisons demonstrated that abdominal pain intensity, the Bristol general score, IBS-SSS score, traditional Chinese medicine (TCM) pattern score, and SDS score were significantly lower in moxibustion group 1 than in moxibustion group 2 at treatment week 6 (P<0.05), and the IBS-QOL score was notably higher in moxibustion group 1 (P<0.05).

Conclusion

Whether at 43 °C or 37 °C, gentle moxibustion at Tianshu (ST25) and Zusanli (ST36) can improve abdominal pain, stool form, and quality of life, reduce disease severity, and mitigate TCM pattern in IBS-D patients; 43 °C gentle moxibustion performs better than 37 °C gentle moxibustion in improving abdominal pain, stool form, disease severity, TCM pattern, quality of life, anxiety, and depression in IBS-D.